SCIESCOPUSQ1
DRUG RESISTANCE UPDATES
CHURCHILL LIVINGSTONE, United Kingdom
DRUG RESISTANCE UPDATES is an academic journal published by CHURCHILL LIVINGSTONE (United Kingdom). Identifiers: ISSN 1368-7646, eISSN 1532-2084. Indexed in SCIE, SCOPUS. Metrics: JIF 21.7, CiteScore 23.2, SJR 5.282, SNIP 3.63. Subject areas: PHARMACOLOGY & PHARMACY. tlooto lists 235 papers from this journal.
CiteScore
23.20
Scopus citation metric
SJR
5.282
SCImago rank
SNIP
3.63
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 1368-7646
- eISSN
- 1532-2084
- Abbreviation
- DRUG RESIST UPDATE
- Publisher
- CHURCHILL LIVINGSTONE
- Country
- United Kingdom
Web of Science categories
SCIEPHARMACOLOGY & PHARMACY
Scopus ASJC categories
1306 Cancer Research2725 Infectious Diseases2730 Oncology2736 Pharmacology (medical)3004 Pharmacology
Keywords
Pharmacology & Pharmacy
Papers in this journal
Recent papers
- Programmed cell death network in cancer drug resistance: A framework for therapeutic intervention.
2026 · 8 citations
- PRKCA and ABCB1 dual-enriched exosomes are key drivers of drug resistance in chronic myeloid leukemia.
2026
- Targeting keratin 6 A overcomes gemcitabine resistance by restoring equilibrative nucleoside transporter 1 and TAM-mediated metabolic compensation in pancreatic cancer.
2026
- Recent advances in near-infrared fluorescent ligands as a novel frontier in combating antibiotic-resistant bacteria.
2026
- Linc01833 drives gemcitabine resistance in non-small cell lung cancer by shielding SLC7A11 from WWP1-mediated ubiquitination and inhibiting ferroptosis.
2026 · 3 citations
Most cited papers
- Collateral sensitivity as a strategy against cancer multidrug resistance
2012 · 321 citations
- Evolution of the serine β-lactamases: past, present and future
2004 · 294 citations
- Drug resistance: Still a daunting challenge to the successful treatment of AML
2012 · 253 citations
- Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine)
2002 · 222 citations
- An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
2021 · 213 citations